The US Food and Drug Administration (USFDA) has said Sun Pharma and Zydus Pharmaceuticals are recalling products in the US ...
Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...
Discover why pharmaceutical-grade supplements command premium prices and whether their higher standards of purity, potency ...
The Wasatch U.S. Select Fund—Investor Class gained 0.24% but underperformed the benchmark Russell 3000® Growth Index, which ...
Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...
Opinion
Voices: I’m a cancer survivor. Prescription drug prices are hurting families like mine across Utah.Pharmaceutical manufacturers are padding their wallets while rural families and retirees are squeezed by a system designed to benefit shareholders, not patients,” writes Tonja Hanson in an op-ed.
Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...
One neat trick involves requesting that prescriptions be processed under a “universal Rx code,” which a pharmacy customer found reduced her medication cost from $252 to $51, suggesting that this ...
We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...
The U.K. government proposes raising mandatory drug rebates paid by drug companies to bolster the National Health Service.
As Filipinos increasingly prioritize health and wellness, Sole Pharma, a leading European pharmaceutical manufacturer, ...
Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results